Venture Capital Firms Look To Vietnam For Health Care Growth
This article was originally published in PharmAsia News
Executive Summary
Venture capitalists see Vietnam as a potentially lucrative venue for investments in health care. Analysts say national spending on health care in Vietnam is only 1.48 percent of gross domestic product, compared with 15.3 percent in the United States and 6 percent in neighboring Thailand. Several venture-capital firms already have committed funds to invest in Vietnam, including Viet Capital Fund Management, which has begun a health care fund with $31.25 million in capital. The fund's director believes the investment will encourage introduction of state-of-the-art diagnostic and treatment technology to Vietnam. (Click here for more
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.